Quick Takeaways
- This page summarizes Max Rosett's Form 4 filing for Immunome Inc. (IMNM).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 31 Jan 2024, 20:53.
Max Rosett - 31 Jan 2024 Form 4 Insider Report for Immunome Inc. (IMNM)
- Signature
- /s/ Sandra Stoneman, Attorney-in-Fact
- Issuer symbol
- IMNM
- Transactions as of
- 31 Jan 2024
- Net transactions value
- $0
- Form type
- 4
- Filing time
- 31 Jan 2024, 20:53:57 UTC
- Previous filing
- 12 Oct 2023
- Next filing
- 17 May 2024
- SEC
- View on sec.gov
Quoteable Key Fact
"Max Rosett filed Form 4 for Immunome Inc. (IMNM) on 31 Jan 2024."
What Changed
- Previous filing in this sequence was filed on 12 Oct 2023.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Source Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMNM | Stock option (right to buy) | Award | $0 | +175,000 | $0.000000 | 175,000 | 31 Jan 2024 | Common Stock | 175,000 | $16.57 | Direct | F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | 25% of the shares subject to the options vest on January 31, 2025, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter. |